As part of the Obama
administration's Prescription Drug Abuse Prevention Plan to tackle the issue of
prescription drug abuse, makers of painkillers have been asked to provide educational materials to help train physicians
about the correct use of these drugs.
The US FDA has sent letters to manufacturers
of opioid drugs asking them to prepare materials which can be useful for the physicians
or prescribers while counseling patients about the risks and benefits of opioid
use. These documents will contain information regarding proper pain
management, patient selection and ensure that their patients understand how to
use these drugs safely. These documents will be approved by the FDA. New
educational guidelines will be required for manufacturers of hydromorphone,
oxycodone, morphine, oxymorphine, morphone, methadone and transdermal fentanyl.
These drugs can be highly addictive.
Prescription drug abuse is an
alarming public health crisis and its overuse can be as dangerous as street
drug abuse. Therefore immediate action
is needed on these lines.